Factors Modifying the Associations of Single or Combination Programmed Cell Death 1 and Programmed Cell Death Ligand 1 Inhibitor Therapies With Survival Outcomes in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis

IMPORTANCE: Programmed cell death 1/programmed cell death ligand 1 (PD-1/PD-L1) inhibitors are immune checkpoint inhibitors widely used in the treatment of metastatic clear cell renal cell carcinoma (ccRCC) and other cancers. There is a lack of understanding regarding which factors are associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sati, Neha, Boyne, Devon J., Cheung, Winson Y., Cash, Sarah B., Arora, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838936/
https://www.ncbi.nlm.nih.gov/pubmed/33496794
http://dx.doi.org/10.1001/jamanetworkopen.2020.34201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838936/
https://www.ncbi.nlm.nih.gov/pubmed/33496794
http://dx.doi.org/10.1001/jamanetworkopen.2020.34201

Ejemplares similares